Sanner offers comprehensive services across design, development, manufacturing, and packaging. These capabilities accelerate delivery and reduce risk from concept through scale-up, reflecting our innovation-driven approach to healthcare product development.
Bringing a product to market takes more than technical expertise. It requires regulatory precision, manufacturing flexibility, and a partner with a deep understanding of medical and pharmaceutical device development, backed by decades of engineering experience.
Our teams in Europe, the US and Asia engage early and remain involved throughout the process, whether providing full-service development or focused support at a specific phase.
Sanner designs medical devices with patients at the center of every decision. By integrating human factors and usability engineering with industrial design services that keep the patient’s needs at the forefront throughout the development process, we gain a deep understanding of users, intended use, and real-world healthcare environments. This human-centered approach ensures that every device is intuitive, easy to use, and aligned with the realities of everyday clinical use.
Our engineers design plastic components that perform as intended and mold reliably at scale. Drawing on more than 60 years of injection molding experience, we apply Design for Manufacturing and Assembly (DFMA) principles from the earliest concepts, shaping part geometry, tolerances, and material selection around how each component will be molded, assembled, and used.
This expertise extends to complex devices such as autoinjectors, pen injectors, and inhalers, where many precision plastic parts must interact reliably within a single mechanism. Drug delivery physics modeling informs how components are designed to deliver consistent dose performance, while electronics integration supports connected and electromechanical devices.
Sanner delivered multiple device development projects for our business unit. In every project, I found them to be excellent. I would highly recommend them, particularly on strategically important device developments where there are significant challenges.
By seamlessly transferring verified designs from development to production within a single trusted partner, Sanner ensures faster market readiness, minimized transition risks, and scalable long-term manufacturing – saving you time, cost, and complexity.
We deliver tailored manufacturing services for companies developing products that require clinical trials and small batch builds. With flexible small-batch manufacturing and specialized regulatory support for drug-device combination products, we help bring new life-saving medical innovations to market.
As a specialist in medical device manufacturing, Sanner transforms innovative healthcare product designs into commercially successful devices through high-precision injection molding, advanced automation, and high-volume manufacturing capabilities. With a global manufacturing network across Europe, Asia, and North America, we provide the capacity, flexibility, and production redundancy needed to support clinical programs, product launches, and long-term commercial supply for drug delivery devices, medical devices, diagnostic products, and active primary packaging.
Regulatory support is built into every stage of Sanner’s product development process. Our in-house team manages submission strategies, handles submissions, and provides technical documentation for medical devices and combination products.
Whether you’re developing a new medical device, scaling a pharmaceutical product, or optimizing an existing design for manufacture, Sanner provides the expertise, infrastructure, and global reach to move your project forward with confidence.
From early-stage design and human factors engineering through to industrialization, manufacturing, and packaging, our integrated CDMO capabilities reduce complexity, accelerate timelines, and help you de-risk every stage of development.
Speak with our team today to explore how we can support your next medical or pharmaceutical innovation.
